The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series

Clinical Trial ID: NCT04041037

Description

A case series involving the concomitant use of MicroMatrix® and Cytal® Wound Matrix 2-Layer with standard of care negative pressure wound therapy (NPWT) during the management of pilonidal wound healing.

This is a prospective case series examining the concomitant use of MicroMatrix® and Cytal® Wound Matrix 2-Layer with standard of care negative pressure wound therapy (NPWT) during the management of pilonidal wound healing. Wound healing will be evaluated at 2 weeks, 6 weeks, and 3 months. If subjects heal prior to the 3 month visit, wound healing will be documented at that visit. A maximum of ten subjects will be included in this series.


Criteria

Inclusion Criteria: 1. Subject has a clinical diagnosis of pilonidal disease. 2. Subject is being scheduled for surgical excision of pilonidal disease. 3. Subject is at least 18 years of age. 4. Subject is willing and able to adhere to protocol requirements and agrees to participate in the study program and comply with the study follow-up regimen. 5. Subject is willing to provide written informed consent. Exclusion Criteria: 1. Subject has a known allergy to porcine-based materials. 2. Subject is pregnant

  • Start Date

    2019-03-26

  • Last Updated

    2019-07-30

  • Sponsor

    ACell Inc.

  • Condition Name

    Pilonidal Disease

Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.